These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells. Okita R; Wolf D; Yasuda K; Maeda A; Yukawa T; Saisho S; Shimizu K; Yamaguchi Y; Oka M; Nakayama E; Lundqvist A; Kiessling R; Seliger B; Nakata M PLoS One; 2015; 10(10):e0139809. PubMed ID: 26439264 [TBL] [Abstract][Full Text] [Related]
9. Immune profile of primary and recurrent epithelial ovarian cancer cases indicates immune suppression, a major cause of progression and relapse of ovarian cancer. Kumar P; Ranmale S; Mehta S; Tongaonkar H; Patel V; Singh AK; Mania-Pramanik J J Ovarian Res; 2023 Jun; 16(1):114. PubMed ID: 37322531 [TBL] [Abstract][Full Text] [Related]
10. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells. Matusali G; Tchidjou HK; Pontrelli G; Bernardi S; D'Ettorre G; Vullo V; Buonomini AR; Andreoni M; Santoni A; Cerboni C; Doria M FASEB J; 2013 Jun; 27(6):2440-50. PubMed ID: 23395909 [TBL] [Abstract][Full Text] [Related]
11. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis]. Guo KY; Mei JZ; Yao KT Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963 [TBL] [Abstract][Full Text] [Related]
12. Exosomes and the MICA-NKG2D system in cancer. Clayton A; Tabi Z Blood Cells Mol Dis; 2005; 34(3):206-13. PubMed ID: 15885603 [TBL] [Abstract][Full Text] [Related]
14. Platelet-derived TGF-β1 mediates the down-modulation of NKG2D expression and may be responsible for impaired natural killer (NK) cytotoxicity in women with endometriosis. Guo SW; Du Y; Liu X Hum Reprod; 2016 Jul; 31(7):1462-74. PubMed ID: 27130956 [TBL] [Abstract][Full Text] [Related]
15. Human placenta expresses and secretes NKG2D ligands via exosomes that down-modulate the cognate receptor expression: evidence for immunosuppressive function. Hedlund M; Stenqvist AC; Nagaeva O; Kjellberg L; Wulff M; Baranov V; Mincheva-Nilsson L J Immunol; 2009 Jul; 183(1):340-51. PubMed ID: 19542445 [TBL] [Abstract][Full Text] [Related]
17. Upregulation of NKG2D ligands and enhanced natural killer cell cytotoxicity by hydralazine and valproate. Chávez-Blanco A; De la Cruz-Hernández E; Domínguez GI; Rodríguez-Cortez O; Alatorre B; Pérez-Cárdenas E; Chacón-Salinas R; Trejo-Becerril C; Taja-Chayeb L; Trujillo JE; Contreras-Paredes A; Dueñas-González A Int J Oncol; 2011 Dec; 39(6):1491-9. PubMed ID: 21805029 [TBL] [Abstract][Full Text] [Related]
18. Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D. Sayitoglu EC; Georgoudaki AM; Chrobok M; Ozkazanc D; Josey BJ; Arif M; Kusser K; Hartman M; Chinn TM; Potens R; Pamukcu C; Krueger R; Zhang C; Mardinoglu A; Alici E; Temple HT; Sutlu T; Duru AD Front Immunol; 2020; 11():40. PubMed ID: 32082316 [TBL] [Abstract][Full Text] [Related]
19. Generation of soluble NKG2D ligands: proteolytic cleavage, exosome secretion and functional implications. Chitadze G; Bhat J; Lettau M; Janssen O; Kabelitz D Scand J Immunol; 2013 Aug; 78(2):120-9. PubMed ID: 23679194 [TBL] [Abstract][Full Text] [Related]
20. Enhanced interaction between natural killer cells and lung cancer cells: involvement in gefitinib-mediated immunoregulation. He S; Yin T; Li D; Gao X; Wan Y; Ma X; Ye T; Guo F; Sun J; Lin Z; Wang Y J Transl Med; 2013 Aug; 11():186. PubMed ID: 23937717 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]